Skip to search formSkip to main contentSkip to account menu

100 ML zoledronic acid 0.05 MG/ML Injection [Reclast]

Known as: ZOLEDRONIC ACID 5 mg in 100 mL INTRAVENOUS INJECTION, SOLUTION [Reclast], Reclast 0.05 MG/ML per 100 ML Injection, Reclast 5 MG per 100 ML Injection 
National Institutes of Health

Related topics

Related topics

8 relations

Broader (1)

100 ML zoledronic acid 0.05 MG/ML Injection
InjectionMannitolReclastWater

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
An open-label study of zoledronic acid (Aclasta 5 mg iv) in the treatment of ankylosing spondylitis
Spinal lesions in ankylosing spondylitis (AS) include osteitis and spondylodiscitis—bone lesions characterised by high signal on… 
Review
2011
Review
2011
Development of bisphosphonate-related osteonecrosis of the jaws in patients treated with annual zoledronic acid infusion (Reclast®) with history of oral bisphosphonate use: a case series
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)